An introduction to our research

The largest charity funder of Parkinson's research in Europe, we've invested over £85million in developing treatments and a cure.

We won't wait

Current Parkinson's drugs aren't good enough. They don't stop, slow or reverse the condition. And despite huge scientific progress, there have been no major advances in Parkinson's treatments in the last decade.

The science is ready, we have the expertise, and new treatments are within our grasp. People with Parkinson's need a breakthrough and we won't wait any longer.

New and better treatments, faster

We're adopting a radical new approach - tackling the critical roadblocks, filling the gaps and investing in big ideas that will speed up the process and deliver treatments to the people who need them, faster.

Unlocking scientific discoveries

We're backing the best and brightest minds to unlock the ideas that will lead to new treatments, and one day a cure.

Fast-tracking better treatments

We invest in the best ideas, wherever they come from, and rapidly turn them into treatments that can be tested and progressed.

Improving clinical trials

We believe clinical trials can work better so we're bringing the right people together to make trials faster, cheaper and more likely to succeed.

Repurposing approved treatments

We're taking the fastest route to better treatments by tracking down drugs already approved and in use for other conditions which have untapped potential for Parkinson's.

Media name
Our research grants 2018 (PDF, 4.4MB)
RSN join us

Get involved in research

Without your support, research can't happen. Find out about the many ways you can help us find a cure for Parkinson's.

Find out more